![](https://i.imgur.com/CLvY2jA.png")
23-09-2021, 03:34 PM
A World Health Organization expert panel is scheduled to review the clinical trial data of Bharat Biotech’s Covid-19 vaccine Covaxin on October 5, according to the committee’s agenda for the meeting.
Following the review, the Strategic Advisory Group of Experts on Immunization (SAGE) will issue draft recommendations, which will be critical in the process of approving Covaxin for WHO’s Emergency-Use Listing (EUL).
EUL is a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the aim of expediting their availability to people affected by a public health emergency.
https://www.moneycontrol.com/news/busine...94261.html
Following the review, the Strategic Advisory Group of Experts on Immunization (SAGE) will issue draft recommendations, which will be critical in the process of approving Covaxin for WHO’s Emergency-Use Listing (EUL).
EUL is a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the aim of expediting their availability to people affected by a public health emergency.
https://www.moneycontrol.com/news/busine...94261.html
